Literature DB >> 18372133

Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria.

E O Iwalewa1, N O Omisore, C O Adewunmi, A A Gbolade, O G Ademowo, C Nneji, O I Agboola, O M Daniyan.   

Abstract

AIM OF THE STUDY: The ethanolic stem bark extract of Harungana madagascariensis (Hypericaceae), (Choisy) Poir were evaluated for their activities on Trichomonas gallinae (Rivolta) Stabler isolated from the pigeon (Columba livia). It was also tested for their anti-malarial activity on N67 Plasmodium yoelii nigeriensis (in vivo) in mice and on Plasmodium falciparum isolates in vitro.
MATERIALS AND METHODS: The anti-trichomonal screening was performed in vitro using Trichomonas gallinae culture. The minimum lethal concentration (MLC) is the lowest concentration of the test extract in which no motile organisms were observed. The anti-malarial effects were determined in-vivo for suppressive, curative and prophylactic activities in mice receiving a standard inoculum size of 1 x 10(7) (0.2 ml) infected erythrocytes of Plasmodium yoelii nigeriensis intraperitoneally, and the in vitro was performed against 3 isolates of Plasmodium falciparum in a candle jar procedures.
RESULTS: The IC(50) of the extract and metronidazole (MDZ) (Flagyl) on Trichomonas gallinae at 48 h are 187 and 1.56 microg/ml. The IC(50) of the extract, chloroquine (CQ) and artemether (ART) on Plasmodium falciparum are between 0.052 and 0.517 microg/ml for the extract and 0.021 and 0.0412 microg/ml for ART and CQ, respectively. The actions of the extract in in vivo study on Plasmodium yoelii nigeriensis showed that in both suppressive and prophylactic tests the percentages chemo-suppressive were between 28.6-44.8% and 30.2-78.2% respectively, while only 80 mg/kg of the extract reduced the parasitaemia level when compared to the control and the standard drugs in curative test.
CONCLUSIONS: Harungana madagascariensis stem bark extract therefore exhibited significant anti-protozoan effects against Trichomonas and Plasmodium both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372133     DOI: 10.1016/j.jep.2008.02.019

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  In-vitro evaluation of anti-trichomonal activities of Eugenia uniflora leaf.

Authors:  Gabriel Femi Ibikunle; Adeleke Clement Adebajo; Funmilayo Gladys Famuyiwa; Adetunji Joseph Aladesanmi; Clement Oladapo Adewunmi
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-12-30

2.  Anti-Trichomonas vaginalis activity of nano Micana cordifolia and Metronidazole: an in vitro study.

Authors:  Hossein Vazini
Journal:  J Parasit Dis       Date:  2017-05-30

3.  Medicinal plants and traditional healing practices in Ehotile people, around the Aby Lagoon (eastern littoral of Côte d'Ivoire).

Authors:  Djah F Malan; Danho F R Neuba; Kouakou L Kouakou
Journal:  J Ethnobiol Ethnomed       Date:  2015-03-14       Impact factor: 2.733

4.  Medicinal plants used for management of malaria among the Luhya community of Kakamega East sub-County, Kenya.

Authors:  Nillian Mukungu; Kennedy Abuga; Faith Okalebo; Raphael Ingwela; Julius Mwangi
Journal:  J Ethnopharmacol       Date:  2016-08-30       Impact factor: 4.360

Review 5.  Antimalarial Plants Used across Kenyan Communities.

Authors:  Timothy Omara
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-12       Impact factor: 2.629

6.  Anti-Trichomonas gallinae activity of essential oils and main compounds from Lamiaceae and Asteraceae plants.

Authors:  María Bailén; Irene Díaz-Castellanos; Iris Azami-Conesa; Sara Alonso Fernández; Rafael A Martínez-Díaz; Juliana Navarro-Rocha; María Teresa Gómez-Muñoz; Azucena González-Coloma
Journal:  Front Vet Sci       Date:  2022-09-09

Review 7.  Plant-derived antimalarial agents: new leads and efficient phytomedicines. Part II. Non-alkaloidal natural products.

Authors:  Ronan Batista; Ademir de Jesus Silva; Alaíde Braga de Oliveira
Journal:  Molecules       Date:  2009-08-13       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.